Internal Medicine, Infectious Disease · San Luis Obispo, CA
NPI
1063492031
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1551 Bishop St Ste 250
San Luis Obispo, CA, 93401
Phone (805) 540-0689
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
1,166 services
Medicare patients, 2024
296
Average age 73
Drug cost, 2024
$495K
497 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher V Holland was code 99233 (hospital e&m - subsequent), 519 times for 202 patients. In total Christopher V Holland billed 1,166 services in 6 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 519 | 202 | $94.22 | $49K |
| 99232 Hospital E&M - Subsequent | Facility | 349 | 108 | $62.66 | $22K |
| 99223 Hospital E&M - Initial | Facility | 194 | 183 | $136.71 | $27K |
| 99214 Office E&M - Established | Office | 89 | 54 | $98.28 | $8,747 |
| 99205 Office E&M - New | Office | 14 | 14 | $146.81 | $2,055 |
By year: 2022 $85K for 890 services; 2023 $131K for 1,307 services; 2024 $108K for 1,166 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher V Holland prescribed most often to Medicare patients was Fluconazole, with 80 prescriptions and refills. In total Christopher V Holland wrote 497 Medicare prescriptions that cost $495K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluconazole Generic | 80 | 194 | 20 | $13K |
| Ceftriaxone Ceftriaxone Sodium | 35 | 35 | 13 | $1,767 |
| Cefazolin Sodium Generic | 29 | 29 | Under 11 | $1,434 |
| Tivicay Dolutegravir Sodium | 27 | 27 | Under 11 | $60K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 26 | 42 | Under 11 | $159K |
| Ampicillin Sodium Generic | 25 | 25 | Under 11 | $2,563 |
| Cephalexin Generic | 20 | 28 | Under 11 | $204 |
| Vancomycin Hcl Generic | 18 | 18 | Under 11 | $1,710 |
| Descovy Emtricitabine/Tenofov Alafenam | 15 | 15 | Under 11 | $32K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 15 | 15 | Under 11 | $60K |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 14 | 14 | Under 11 | $1,581 |
| Micafungin Micafungin Sodium | 14 | 14 | Under 11 | $5,793 |
| Amoxicillin Generic | 13 | 35 | Under 11 | $201 |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 13 | 13 | Under 11 | $7,254 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 13 | 13 | Under 11 | $45K |
Brand drugs: 133 claims; generic drugs: 364 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Christopher V Holland were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.